$STX #Shield Therapeutics Shield Therapeutics - Tim Watts succeeds Carl Sterritt as CEO: Shield Therapeutics (STX) has announced that founder Carl Sterritt has resigned from his role as CEO with mutual agreement from its main… https://t.co/0UPPQUxzCc #equity #stocks https://t.co/mEuNDfBPdi